Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Travere Therapeutics Inc shares valued at $47,424 were sold by ROTE WILLIAM E. on Jan 22 ’25. At $19.46 per share, ROTE WILLIAM E. sold 2,437 shares. The insider’s holdings dropped to 83,170 shares worth approximately $1.7 million following the completion of this transaction.
Also, Dube Eric M sold 10,736 shares, netting a total of over 208,923 in proceeds. Following the sale of shares at $19.46 each, the insider now holds 351,239 shares.
Before that, REED ELIZABETH E had sold 2,437 shares from its account. In a trade valued at $47,424, the SVP, GC & CORPORATE SECRETARY traded Travere Therapeutics Inc shares for $19.46 each. Upon closing the transaction, the insider’s holdings decreased to 2,437 shares, worth approximately $1.57 million.
As published in their initiating research note from Cantor Fitzgerald on January 10, 2025, Travere Therapeutics Inc [TVTX] has been an Overweight. Analysts at Wells Fargo upgraded the stock from ‘”an Equal weight”‘ to ‘”an Overweight”‘ outlook in a report released in late October. As of October 16, 2024, Scotiabank has initiated its “Sector outperform” rating for TVTX. Earlier on September 09, 2024, Guggenheim upgraded its rating. Their new recommendation was “a Buy” for TVTX stock which previously was a “a Neutral”.
Analyzing TVTX Stock Performance
During the last five days, there has been a surge of approximately 5.09%. Over the course of the year, Travere Therapeutics Inc shares have jumped approximately 17.39%. Shares of the company reached a 52-week high of $21.56 on 01/24/25 and a 52-week low of $16.80 on 01/14/25. A 50-day SMA is recorded $18.47, while a 200-day SMA reached $12.53. Nevertheless, trading volume fell to 1.09 million shares from 1.34 million shares the previous day.
Support And Resistance Levels for Travere Therapeutics Inc (TVTX)
According to the 24-hour chart, there is a support level at 19.71, which, if violated, would cause prices to drop to 18.98. In the upper region, resistance lies at 21.25. The next price resistance is at 22.06. RSI (Relative Strength Index) is 60.09 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.32, which suggests the price will increase in the coming days. Percent R is at 23.32%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
